Abstract:Abstract Background and Aims Regenerating protein 1a (Reg 1a) is a secretory protein mostly produced by the pancreas. Serum levels of Reg 1a has been found increased in patients with diabetic nephropathy, which may be a potential indicator of renal dysfunction. Here, we investigated whether Reg 1a was associated with renal function in chronic kidney disease (CKD) and further to evaluate its predictive value of progress in renal dysfunction. Method Serum Reg 1a levels were measured by a double antibody sandwich ELISA enzyme-linked immunosorbent assay. Demographics information and clinical biochemical parameters such as blood urea nitrogen (BUN), serum creatinine (Scr), uric acid (UA) and urinary albumin-to-creatinine ratio (UACR) were collected. Correlations between serum Reg 1a and other factors were presented by Spearman's correlation coefficient and partial correlation analysis. Multivariate logistic regression analysis was utilized to identify the independent risk factors for chronic renal dysfunction and the progress in CKD. Draw the receiver operating characteristic curve (ROC curve) and calculate the area under the curve (AUC) to analyze the effectiveness of the individual serum Reg 1a. Statistical analyses were conducted using SPSS 20.0 software, Med-Calc statistical software. Results A total of 640 participants were enrolled in this study including non-CKD subjects (n = 240) and patients with CKD (n = 400). Compared with non-CKD group, participants in CKD group had higher level of serum reg 1a (188.2 [66.7∼387.6] ng/ml vs 23.8 [14.7∼35.1] ng/ml, P<0.001). Serum reg 1a level elevated with increasing grades of CKD. Serum reg 1a was negatively correlated with eGFR and positively associated with age, hypertension, Scr, BUN, UA and UACR (P<0.001). In multiple logistic regression analysis, serum reg 1a was one of independent risk factors to predict renal dysfunction (OR = 1.010 [1.003, 1.018], P = 0.008). The AUC for serum reg 1a to predict CKD was 0.889 [0.862, 0.913], and the AUC for serum reg 1a to screen the eGFR lower than 30 ml/min/1.73 m2 in CKD groups was 0.919 [0.888, 0.944]. Subgroup analysis showed that serum reg 1a is an independent risk factor to predict early progress of UACR (OR = 1.012 [1.002, 1.022], P = 0.016) in CKD patients. Conclusion The study provides clinical evidence that serum reg 1a may a meaningful biomarker of early kidney impairment and a useful supplementary factor in the progression of CKD.

Urinary levels of regenerating protein Iα do not differentiate celiac patients and healthy subjects

Biomarkers for diagnosis and monitoring of celiac disease

Itraq-Based Comparative Proteomics Analysis Reveals Specific Urinary Biomarkers for Various Kidney Diseases.

Serum levels of galactose-deficient IgA are elevated in patients with IgA nephropathy but do not correlate to disease activity or progression

Urinary excretion of gluten immunoreactive peptides as an indicator of gastrointestinal function after fasting and dietary provocation in healthy volunteers

Urinary low-molecular-weight protein excretion in pediatric idiopathic nephrotic syndrome

Urinary C-X-C Motif Chemokines 13 is a Noninvasive Biomarker of Antibody-Mediated Renal Allograft Rejection

Urinary Serum- and Glucocorticoid-Inducible Kinase SGK1 Reflects Renal Injury in Patients with Immunoglobulin A Nephropathy

#4948 ROLE OF REGENERATING PROTEIN 1A IN THE PROGRESSION OF CHRONIC KIDNEY DISEASE

The use of urine peptidomics to define dietary gluten peptides from patients with celiac disease and the clinical relevance

A Novel Biomarker for Post-Transplant Recurrent IgA Nephropathy

Introducing New Potential Biomarkers for Celiac Disease among the Genes Extracted from General Databases

Circulating miRNAs as Potential Biomarkers for Celiac Disease Development

Non-Invasive Biomarkers for Celiac Disease

Clinical Significance of Urinary Biomarkers in Patients with Primary Focal Segmental Glomerulosclerosis.

Endomysial Antibodies as Unreliable Markers for Slight Dietary Transgressions in Adolescents with Celiac Disease

Urinary N-Acetyl-Beta-D-Glucosaminidase levels predict immunoglobulin a nephropathy remission status

Gluten immunogenic peptide excretion detects dietary transgressions in treated celiac disease patients

Urinary Soluble CD163 Levels Predict IgA Nephropathy Remission Status

Determination of Urinary Gluten Immunogenic Peptides to Assess Adherence to the Gluten-Free Diet: A Randomized, Double-Blind, Controlled Study

Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases